Skip to search formSkip to main contentSkip to account menu

Osteoporosis

Known as: OSTEOPOROSE, Osteoporosis [Disease/Finding], Osteoporoses 
A condition of reduced bone mass, with decreased cortical thickness and a decrease in the number and size of the trabeculae of cancellous bone (but… 
National Institutes of Health

Related topics

Related topics

50 relations
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2Bone Demineralization, PathologicBruck syndrome 1CALCA gene

Broader (1)

Metabolic Bone Disorder

Narrower (5)

Osteoporosis, PostmenopausalOsteoporotic FracturesTRANSIENT REGIONAL OSTEOPOROSISWinchester syndrome (disorder)

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
Wnt/beta-catenin signaling: components, mechanisms, and diseases.
Highly Cited
2009
Highly Cited
2009
Denosumab for prevention of fractures in postmenopausal women with osteoporosis.
BACKGROUND Denosumab is a fully human monoclonal antibody to the receptor activator of nuclear factor-kappaB ligand (RANKL) that… 
Highly Cited
2007
Highly Cited
2007
Incidence and Economic Burden of Osteoporosis‐Related Fractures in the United States, 2005–2025
This study predicts the burden of incident osteoporosis‐related fractures and costs in the United States, by sex, age group, race… 
Highly Cited
2007
Highly Cited
2007
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.
BACKGROUND A single infusion of intravenous zoledronic acid decreases bone turnover and improves bone density at 12 months in… 
Review
2005
Review
2005
Pathogenesis of osteoporosis: concepts, conflicts, and prospects.
  • L. Raisz
  • Journal of Clinical Investigation
  • 2005
  • Corpus ID: 44866778
Osteoporosis is a disorder in which loss of bone strength leads to fragility fractures. This review examines the fundamental… 
Highly Cited
2004
Highly Cited
2004
Grading quality of evidence and strength of recommendations
Abstract Users of clinical practice guidelines and other recommendations need to know how much confidence they can place in the… 
Review
2001
Review
2001
Osteoporosis prevention, diagnosis, and therapy.
OBJECTIVES To clarify the factors associated with prevention, diagnosis, and treatment of osteoporosis, and to present the most… 
Highly Cited
1998
Highly Cited
1998
osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Osteoprotegerin (OPG) is a secreted protein that inhibits osteoclast formation. In this study the physiological role of OPG is… 
Highly Cited
1997
Highly Cited
1997
Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density
Highly Cited
1992
Highly Cited
1992
The diagnosis of osteoporosis
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)